Boiron

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
>
No longer registered as of 07 Oct 2024 - Registration as it was on 05 Oct 2023
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 036150720595-02

Overview

Lobbying Costs

50,000€ - 99,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Boiron

    EU Transparency Register

    339652421108-93 First registered on 21 Mar 2016

    Goals / Remit

    Boiron is the n°1 manufacturer of homeopathic medicinal products in Europe. Its involvement at EU level aims at insuring that patients throughout Europe have access to the same high level of information on homeopathic medicines.

    Main EU files targeted

    - Pharmaceutical Strategy for Europe

    - Directive 2001/83 on medicinal products for human use

    - Regulation 2019/6 on veterinary medicinal products

    - Antimicrobial Resistance

    - Europe's Beating Cancer Plan

    Address

    Head Office
    2, avenue de l'Ouest Lyonnais
    Messimy 69510
    FRANCE
    EU Office
    2, avenue de l'Ouest Lyonnais
    Messimy 69510
    FRANCE

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 27 Dec 2024

    Name Start date End Date
    Ms Melanie BELSKY 19 Jul 2016 01 Jul 2017

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Association of the European self-medication industry (associate member) - AESGP

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    50,000€ - 99,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    political intelligence 50,000€ - 99,999€

    Intermediaries for current year

    Name
    political intelligence

    Closed year Costs

    50,000€ - 99,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    MEP Interest Group on Integrative Medicine & Health

    Communication activities

    Event 'Integrative Oncology - The Missing Link in Europe's Beating Cancer Plan' - 14 October 2021

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 27 Sep 2017 Location Brussels
      Subject Discussion on AMR
      DG Health and Food Safety
      Attending
      • Xavier Prats Monné (Director-General)
Download this datacard